NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 1 filers reported holding NOVUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | +100.0% | 4,200 | +13.1% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 3,715 | +123.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 1,666 | +57.0% | 0.00% | – |
| Q4 2018 | $2,000 | -84.6% | 1,061 | -58.3% | 0.00% | – |
| Q1 2018 | $13,000 | -13.3% | 2,547 | -31.4% | 0.00% | – |
| Q4 2017 | $15,000 | -16.7% | 3,713 | +7.4% | 0.00% | – |
| Q3 2017 | $18,000 | +800.0% | 3,457 | +784.1% | 0.00% | – |
| Q2 2017 | $2,000 | – | 391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 80,069 | $1,233,000 | 0.56% |